Cost Effectiveness of Sequencing 34 Cancer-Associated Genes as an Aid for Treatment Selection in Patients with Metastatic Melanoma

OBJECTIVE: To determine whether a next-generation sequencing (NGS) panel of 34 cancer-associated genes would cost-effectively aid in the treatment selection for patients with metastatic melanoma, compared with a single-site BRAF V600 mutation test. METHODS: A decision model was developed to estimate...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Mol Diagn Ther
Autores principales: Li, Yonghong, Bare, Lance A., Bender, Richard A., Sninsky, John J., Wilson, Leslie S., Devlin, James J., Waldman, Frederic M.
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4469775/
https://ncbi.nlm.nih.gov/pubmed/25926090
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40291-015-0140-9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares